About ASD Closure
ASD (Atrial Septal Defect) closure is a procedure, performed to repair a hole in wall that is separating the heart’s upper chambers. This can be done through minimally invasive catheter-based techniques or open-heart surgery, depending on the size and location of the defect.
The main purpose is to prevent abnormal blood flow between the atria, and reduce the risk of complications such as stroke and heart failure, and improve the patient’s overall cardiac function and quality of life.
Why choose India for ASD closure?
India stands well-known for world-class congenital heart defect treatment at a fraction of cost, compared to western countries. Cardiac surgeons and interventional cardiologists are highly skilled in performing surgical and catheter-based ASD closures. They have been trained at prestigious institutions both in India and abroad.
They use advanced equipment and best healthcare facilities in structural heart interventions. Patients can expect quality treatment that matches best standards, offered in many advanced Western countries.
The main purpose is to prevent abnormal blood flow between the atria, and reduce the risk of complications such as stroke and heart failure, and improve the patient’s overall cardiac function and quality of life.
Why India is a Preferred Destination?
Many patients travel to India for various congenital heart defect repairs, such as transcatheter ASD closure, surgical ASD repair, and closure of complex defects including secundum, primum, and sinus venosus types. India continues to firmly establish its position as a leader in treating congenital heart diseases on the global stage.
Why Indian Hospitals Are best for ASD closure?
Many hospitals offer a full range of ASD closure procedures. Ranging from minimally invasive device closures using Amplatzer or similar occluders to open surgical repairs for larger or complex defects, in children and adults. They have advanced technology including 3D echocardiography and catheterization labs, to treat various types of atrial septal defects with excellent outcomes.
